Australia, Feb. 18 -- Kite Pharma Inc., owns the trademark (2504250) for 'DAKVANNI' till Nov. 5, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical and biological preparations for immunotherapy, including for T-Cell immunotherapy; pharmaceutical preparations for the treatment of oncological and blood disorders.]
Type of Mark: Word
Date of Acceptance: Dec. 10, 2024
Registration Advertised: Feb. 17
For further details contact Jack Wessel Gilead Sciences Inc. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2504250.
Disclaimer: Curated by HT Syndication....